Screening and management protocols for group B streptococcus in pregnancy.

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Infectious Diseases

Background:

• Group B Streptococcus (GBS) infection is a major cause of newborn illness and death.
• Current screening and intrapartum antibiotic protocols aim to reduce early-onset GBS disease in neonates.

Purpose of the Study:

• To review the advantages and disadvantages of current Group B Streptococcus screening and treatment protocols.
• To address the ongoing controversy regarding the optimal approach for GBS management in pregnancy.

Main Methods:

• Review of existing literature on Group B Streptococcus screening methods (antepartum cultures, risk factors).
• Analysis of the efficacy and limitations of intrapartum antibiotic prophylaxis.
• Evaluation of the benefits and harms associated with current GBS management protocols.

Main Results:

• Current protocols reduce, but do not completely prevent, early-onset GBS disease.
• Controversy persists regarding the most effective screening and treatment strategies.
• Intrapartum antibiotics carry risks and may lead to overtreatment in some women.

Conclusions:

• Existing Group B Streptococcus screening and treatment protocols require critical evaluation.
• Further research is needed to optimize GBS prevention strategies for newborns.
• Balancing the benefits and harms of intrapartum antibiotics remains a key challenge.